Diabetes Case Presentations Irl B. Hirsch, MD-Disclosures Research: - - PowerPoint PPT Presentation

diabetes case presentations irl b hirsch md disclosures
SMART_READER_LITE
LIVE PREVIEW

Diabetes Case Presentations Irl B. Hirsch, MD-Disclosures Research: - - PowerPoint PPT Presentation

Diabetes Case Presentations Irl B. Hirsch, MD-Disclosures Research: Sanofi Diabetes, Halozyme Consulting: Abbott, Roche QUESTION 1 Case 1 An obese 40 year-old woman is admitted for asthma. She received a dose of methylprednisolone in


slide-1
SLIDE 1

Diabetes Case Presentations

slide-2
SLIDE 2

Irl B. Hirsch, MD-Disclosures

  • Research: Sanofi Diabetes, Halozyme
  • Consulting: Abbott, Roche
slide-3
SLIDE 3

Case 1

  • An obese 40 year-old woman is admitted for asthma.

She received a dose of methylprednisolone in the ED at 7pm and will now be receiving 40 mg of oral prednisone daily in the AM. She had not been on any steroids for many years.

  • Random finger-stick blood glucose when she gets to

the floor at 10pm is 275 mg/dL. Her last meal was at 5pm.

  • Her BMI is 25 m/kg2. Her last pregnancy was 10 years

ago and she did not have gestational diabetes. She currently has no symptoms to suggest diabetes.

QUESTION 1

slide-4
SLIDE 4

Besides Ordering a HbA1c and Low- Dose Correction Dose Insulin, What Will You Do for Her Hyperglycemia?

  • A) Begin insulin glargine starting now at 10 units
  • B) Begin insulin glargine starting now at 10 units and

pre-meal insulin lispro between 0.05 and 0.10 u/kg/meal

  • C) Begin AM NPH insulin at 10 units
  • D) Begin pre-mix 70% NPH 30% regular insulin before

breakfast and dinner at 0.2 units/injection

  • E) Begin insulin aspart between 0.05 and 0.10

u/kg/meal

slide-5
SLIDE 5

HOW DO STEROIDS IMPACT BLOOD GLUCOSE?

slide-6
SLIDE 6

Important Concepts

  • Liver is responsible for fasting glycemia
  • Muscle is responsible for post-prandial glycemias
slide-7
SLIDE 7

Effect of Single Dose of Dexamthasone in Normal Persons (48 h)

Glucose Insulin

Abdelmannan et al. Endo Practice, 2010;16:770-777

slide-8
SLIDE 8

OGTT with 8 mg Dex in NGT Subjects*

*all with at least

  • ne first degree

releative with T2DM GLUCOSE INSULIN DAY 2, DEX DAY 2, DEX Note the minimal change in fasting glucose and insulin levels on day 2 Taheri N: Endo Pract 2012;18:855-863

slide-9
SLIDE 9

Bottom Line

  • The Rx of steroid-induced hyperglycemia needs to

focus on the post-prandial glucose levels

  • Therefore, the emphasis for these patients needs to

be with the use of prandial insulins

  • Fasting hyperglycemia is generally seen with higher

doses of steroids, often given long-term, and more

  • ften with previous histories of type 2 DM, pre-

diabetes, or family history of DM

slide-10
SLIDE 10

Prandial Insulin Pearls

slide-11
SLIDE 11

What Is Duration of Action (Glucose Lowering Activity) of Our Current Rapid-Acting Analogues?

  • A) 2 hours
  • B) 3 hours
  • C) 4 hours
  • D) 5 hours
  • E) 6 hours

Given in the typical doses of 0.1-0.2 units per injection

QUESTION 2

slide-12
SLIDE 12

4 5

Serum insulin levels (ng/mL) Time (hours)

Insulin Lispro 3 2 1 1 2 3 4 5 6 7 8 9 10 11 12 Regular Human Insulin R

Lispro vs. Regular

Diabetes 43: 396-402, 1994

slide-13
SLIDE 13

Time (hours)

insulin lispro regular human insulin

Glucose Infusion Rates (mg/mln)

100 200 300 400 500 600 1 2 3 4 5 6 7 8 9 10 11 12

Lispro vs. Regular

Diabetes 43: 396-402, 1994

slide-14
SLIDE 14

Glucodynamic Principles: Prandial Insulin:

not as rapid acting as we thought!

Glucose Infusion Rate (mg/kg•min) 0.2 IU/kg SQ Time (minutes)

Insulin Aspart Regular Insulin

120 240 360 480 600 800 700 600 500 400 300 200 100

Euglycemic clamp profiles

slide-15
SLIDE 15

0 1 2 3 4 5 6 7 8 % insulin remaining

20 40 60 80 100

Insulin insulin aspart “insulin action” disappearance curves

slide-16
SLIDE 16

Why in the Hospital We Don’t Use Between-Meal Insulin Routinely

♦ ACTIVE INSULIN (insulin remaining) ♦ The amount of insulin from the last bolus which has not yet been absorbed based on pharmacodynamic (not pharmacokinetic) data ♦ INSULIN STACKING ♦ Using correction dose insulin to treat before-meal or between-meal hyperglycemia in a situation when there is still significant active insulin

slide-17
SLIDE 17

QUESTION 3

  • A) 15 min after the meal is eaten
  • B) At the time the meal is eaten
  • C) 15 min before the meal is eaten
  • D) 30 min before the meal is eaten

For this woman on prednisone, and a pre- meal glucose of 180 mg/dL, when should the prandial insulin be injected in relation to when the food is eaten?

slide-18
SLIDE 18

300

Timing of Rapid-Acting Analog Insulin Injection Alters PPG in T1DM

Rassam AG, et al. Diabetes Care. 1999;22:133-136. Cobry E, et al. Diabetes Technol Ther. 2010;12:173-177.

8.6 kcal/kg breakfast Minutes BG Level (mg/dL)

288 252 216 180 144 108 72 36

  • 30

30 60 240 90 270 120 150 180 210

–30 m –15 m 0 m +15 m Injection-Meal Interval (minutes)

Insulin Lispro

300

Standardized breakfast Minutes BG Level (mg/dL)

288 252 216 180 144 108 72 36

  • 30

30 60 240 90 270 120 150 180 210

–20 m 0 m +20 m

Insulin Glulisine

Injection-Meal Interval (minutes)

slide-19
SLIDE 19

QUESTION 4

Case 2

  • You are evaluating a 60 year-old man with aortic

stenosis scheduled for aortic valve replacement within the week. You note a random glucose of 185 mg/dL but a HbA1c of 5.1% (normal <6%).

  • How should you proceed?
slide-20
SLIDE 20

Question 4: How To Proceed?

  • A) Order a fructosamine level
  • B) Order a glycated albumin
  • C) Order a fasting glucose
  • D) Order a fasting insulin level
  • E) Order a 1,5 anhydroglucitol level
slide-21
SLIDE 21

Don’t Believe Every Lab Test You Order

Circulation 1963;32:570-581

AD, AP, and multiple valve prosthesis with 25% reduction in RBC survival

slide-22
SLIDE 22

What Alters A1C

Hematologic conditions Anemia Accelerated erythrocyte turnover Thalassemia Sickle cell disease Reticulocytosis Hemolysis Physiologic States Aging Pregnancy Drugs/Medications Alcohol Opioids Vitamin C Vitamin E Aspirin Erythropoetin Dapsone Ribavirin Disease States HIV infection Uremia Hyperbilirubinemia Dyslipidemia Cirrhosis Hypothyroidism* Medical Therapies Blood transfusion Hemodialysis Miscellaneous Glycation rate Protein turnover Race and ethnicity* Laboratory assay Glycemic Variability Smoking Mechanical heart valves Exogenous testosterone?

In a typical diabetes practice, 14% of A1C measurements are misleading

slide-23
SLIDE 23

QUESTION 5

CASE 3

  • It is midnight and you are called to the ER for a an 80

kg patient who 30 min previously accidently took 80 units of insulin lispro instead of his insulin glargine. His blood glucose at the time is 130 mg/dL.

  • You order intravenous dextrose to maintain his blood

glucose above 100 mg/dL

slide-24
SLIDE 24

Question 5

  • How long will this patient require intravenous

dextrose?

  • A) 5 hours
  • B) 6 hours
  • C) 7 hours
  • D) 8 hours
  • E) 12 hours
slide-25
SLIDE 25

PK of Insulin Lispro

Gagnon-Auger M. Diabetes Care. 2010;33:2502-2507. 10 units, control 10 units, type 2 diabetes 30 units, type 2 diabetes 50 units, type 2 diabetes 8h

slide-26
SLIDE 26

CASE 4

  • You are caring for a 29 year-old woman with type 1

diabetes who was admitted due to an MVA. She required an exploratory laparotomy due to bleeding and is now slowing recovering. Her baseline Hct is 44% and it is now 25%.

  • Her diabetes is complicated by advanced non-

proliferative retinopathy and microalbuminuria. Her eGFR is 55. There has never been a concern of coronary artery disease and her EKG now is normal. She has never been a smoker.

  • Besides insulin her home medications include lisinopril

and an OCP

QUESTION 6

slide-27
SLIDE 27

Question 6

  • At this point what should you do?
  • A) Transfuse at least to a Hct of 30%
  • B) Increase the lisinopril to maintain a blood pressure

below 120

  • C) Maintain goal glucose of 90-130
  • D) Begin low-dose prednisone
slide-28
SLIDE 28

Anemia and DR

  • Acute anemia (not chronic) appears to result in

worsening of diabetic retinopathy – Mechanism appears to be ischemia to retina

  • No RCTs but if known retinopathy consensus is to

transfuse to Hct of 30% if pre-event Hct known to be normal.

slide-29
SLIDE 29

Case 5

  • A 50 year-old man with type 2 diabetes is admitted

for a neuropathic foot ulcer. He also has severe non- proliferative retinopathy and a recent history of clinically significant macular edema

  • His medications include metformin, glipizide,

sitagliptin, atorvastatin, HCTZ, ramipril, and atenolol

  • Pertinent lab includes a creatinine level of 1.0 and a

HbA1c of 11.3%. He has no albuminuria

  • You explain to him his diabetes is poorly controlled

and he agrees it is time to start insulin therapy

QUESTION 7

slide-30
SLIDE 30

Question 7

  • His glycemic targets now and for the next few

months should be:

  • A) 80-110
  • B) 110-140
  • C) 140-180
  • D) 180-220
slide-31
SLIDE 31

What You Need To Know

  • Abrupt normalization of glucose, generally when the

HbA1c is > 10% and there is advanced non- proliferative retinopathy can lead to a worsening of the retinopathy (ischemic mechanism)

  • If no retinopathy is present there is no concern about

how quickly the glucose is normalized

  • Unclear how slowly the HbA1c can be reduced but it

should be done in conjunction with a retinal specialist (reports from the 1990s suggest 2% reduction per year)

slide-32
SLIDE 32

Case 6

  • You are caring for a patient who had a recent

pancreatectomy without a previous history of diabetes.

QUESTION 8

slide-33
SLIDE 33

Question8

  • What insulin regimen should you provide?

A) glargine/mealtime lispro; 0.7 units/kg B) glargine/mealtime lispro; 0.3 units/kg C) Twice daily NPH/Regular 0.7 units/kg D) Twice daily detemir with twice daily aspart 0.5 units/kg E) Twice daily detemir with mealtime aspart 0.5 units/kg with liraglutide

slide-34
SLIDE 34

Case 7

  • It is decided to begin nocturnal tube feeding on a

patient with known type 2 diabetes, HbA1c 7%. At home he receives metformin, exenatide, and insulin

  • glargine. He has been eating minimal food in the

hospital receiving bedtime insulin glargine and postprandial lispro based on the amount of food he had consumed.

QUESTION 9

slide-35
SLIDE 35

Question 9

  • What is the best insulin regimen to use now, on top
  • f the glargine/lispro

– A) increase the bedtime glargine dose – B) increase the bedtime glargine dose and add a dose of morning glargine – C) add a dose of bedtime NPH insulin – D) add a dose of bedtime NPH insulin with insulin lispro – E) add bedtime metformin and morning pioglitazone

slide-36
SLIDE 36

Case 8

  • A 45 year-old man s/p bone marrow transplant is

receiving high-dose steroids. His appetite has improved on the steroids and he wants to eat. He had been receiving intravenous insulin requiring between 20-25 units/hour (480 to 600 units/day) to control his blood glucose when not eating.

  • He is not in an ICU

QUESTION 10

slide-37
SLIDE 37

Question 10

  • Which insulin regimen will you order (which will also

control his blood glucose!)? – A) Increase the intravenous insulin 2X during his meal – B) Discontinue the intravenous insulin, convert his basal insulin to insulin glargine given BID, and start premeal lispro at 0.1 units/kg – C) Continue the intravenous insulin, begin SC insulin lispro before meals at 0.2 units/kg – D) Convert the intravenous insulin dose to SC U-500 insulin to be giving in the AM with insulin lispro before meals at 0.2 units/kg